Most type 2 diabetes patients tolerate semaglutide well, but those on insulin or sulfonylureas need dose adjustments to prevent dangerously low blood sugar
Exendin-4, the GLP-1 analogue, is better studied, with an estimated half-life of 18-41 minutes for IV administration in rat models (see reference 6)
A potentially more clinically realistic analysis testing the impact of continuing oral semaglutide and liraglutide alongside basal insulin therapy before intensification to basal-bolus insulin was also explored, and this showed further benefits in clinical outcomes and cost-effectiveness were possible with oral semaglutide (Table 3 and Fig
Isotani, A
Not only the protection of the integrity of the blood-brain barrier, this whole neuroglial vascular unit, the myelin sheath protection, reducing inflammation within the brain, improving the glymphatic flow, which is of course critical for clearing waste and promoting cerebral vascular remodeling and more, so the brain effects here is what it seems to be
More questions to ask Still interested in learning more